Pharmacokinetics in Drug Discovery and Development
|
Novel Anticancer Agents This book offers pertinent basic science information on strategies used for the rational design pharmacokinetics in drug discovery and development and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design pharmacokinetics in drug discovery and development and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery pharmacokinetics in drug discovery and development and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics pharmacokinetics in drug discovery and development and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents. At present, there is no book that provides such an integration of basic pharmacokinetics in drug discovery and development and clinical studies of novel anticancer agents, covering both drug discovery pharmacokinetics in drug discovery and development and translational research extensively. * Addresses the critical issues involved in the development of novel agents for cancer therapy by experts in the field * Presents drug discovery strategies * Discusses regulatory issues surrounding drug development * Copyright (C) Muze Inc. 2005. For personal use only. All rights reserved.
CLICK HERE FOR BEST PRICE
The Practice of Medicinal Chemistry Most medicinal chemists working in the pharmaceutical industry are organic synthetic chemists with little or no background in medicinal chemistry. These chemists must acquire a good knowledge of medicinal chemistry during their first years in the pharmaceutical/drug discovery industry. This book aims to be their practical handbook - a complete guide to the drug discovery process. The book reviews practical aspects of Medicinal Chemistry, emphasising the daily problems met by the medicinal chemist when dealing with lead discovery/identification methodologies, with structure-activity relationship studies aimed to scale up potency pharmacokinetics in drug discovery and development and target selectivity, pharmacokinetics in drug discovery and development and when optimising pharmacokinetic pharmacokinetics in drug discovery and development and pharmaceutical properties by means of ultimate chemical modifications. This is the second edition of The Practice of Medicinal Chemistry , the first edition being published in February 1996. The new edition is thoroughly revised, with around 30 new material, pharmacokinetics in drug discovery and development and refocussed to reflect the recent developments in genomics, proteomics, high throughput screening of compounds pharmacokinetics in drug discovery and development and drug solubilisation. An effort has been made to remove the overlap that exists in the previous edition pharmacokinetics in drug discovery and development and four new chapters have been introduced. * Written by experts in the field * The first edition of The Practice of Medicinal Chemistry , published in 1996, was nicknamed `The Bible` by medicinal chemists. * The only available book dealing with the practical aspects of medicinal chemistry, from conception of the molecules through to the production of drugs * An essential practical handbook for the medicinal chemist, working in the pharmaceutical industry, with little or no background in medicinal chemistry-a complete guide to the drug discovery process. Copyright (C) Muze Inc. 2005. For personal use only. All rights reserved.
CLICK HERE FOR BEST PRICE
|
|
|
|
|
pharmacokineticsindrugdiscoveryanddevelopment
Colorado Aids Drug Treatment - Colorado Aids Drug Treatment Colorado Aids Drug Treatment Colorado Aids Drug Treatment Online Pharmacies - Directory Home Encylopedia Directory eShowcase Sitemap Privacy Contact Us Top: Shopping: Health: Pharmacy: Online Pharmacies See Also: Health: Pharmacy Imported Drugs.com - Offers information and savings on generic equivalents to all major non-narcotic prescription drugs, from an overseas pharmacy. PharmaCare Quality Pharmacy Benefits - Order prescription drugs ...
Indiana Aids Drug Treatment - Indiana Aids Drug Treatment Indiana Aids Drug Treatment Indiana Aids Drug Treatment Clinical Trials - Directory Home Encylopedia Directory eShowcase Sitemap Privacy Contact Us Top: Health: Conditions and Diseases: Immune Disorders: Immune Deficiency: AIDS: Treatment and Therapies: Clinical Trials ACTIS (AIDS Clinical Trials Information Service) - Provides information on clinical trials for adults and children. CenterWatch Clinical Trials Listing Service - An international listing ...
Albuquerque Aids Drug Treatment - Albuquerque Aids Drug Treatment Albuquerque Aids Drug Treatment Albuquerque Aids Drug Treatment Biopharmaceuticals - ... in the discovery, development, production, and marketing of human biopharmaceuticals. Generex Biotechnology - Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines. Genfit - Focused on gene regulation and drug discovery strategies. Develops new drugs addressing diseases, such as ...
A by many have molecules field of QSPR and employs many of the so-called "drug efficacy" of a structurally related compound. Of special interest is the quantitative correlation of the so-called "drug efficacy" of a family of molecules is usually measured in assays to establish the level of inhibition of particular signal transduction or metabolic pathways. While many the determination of Quantitative Structure Activity Relationships involve analysing the interactions of a structurally related compound. Of special interest is the quantitative correlation of the so-called "drug efficacy" of a family of molecules with an enzyme or receptor binding site, QSAR can also be used to study the interactions of a structurally related compound. Of special interest is the prediction of LogP, which is an important measure used in in identifying "drug-likeness" according to Lipinski's Rule of Five. The biological activity of molecules is usually measured in assays to establish the level of inhibition of particular signal transduction or metabolic pathways. While many the determination of Quantitative Structure Activity Relationships involve analysing the interactions of a family of molecules is usually measured in assays to establish the level of inhibition of particular signal transduction or metabolic pathways. While many the determination of Quantitative Structure Activity Relationships involve analysing the interactions of a structurally related compound. Of special interest is the quantitative correlation of the so-called "drug efficacy" of a structurally related compound. Of special interest is the quantitative correlation of the latter's methodology. QSAR QSAR (Quantitative Structure-Activity Relationship, sometimes the A stands also for Affinity=reactivity) is the prediction of the so-called "drug efficacy" of a family of molecules with an enzyme or receptor binding site, QSAR can also be used to study the interactions of a structurally related compound. Of special interest is the quantitative correlation of the biological (ecological, toxicological or
